Relationship between cerebral pharmacokinetics and anxiolytic activity of diazepam and its active metabolites after a single intra-peritoneal administration of diazepam in mice

被引:8
作者
Dailly, E [1 ]
Hascoët, M [1 ]
Colombel, MC [1 ]
Jolliet, P [1 ]
Bourin, M [1 ]
机构
[1] Univ Nantes, Fac Med, Dept Pharmacol, F-44035 Nantes, France
关键词
diazepam; desmethyldiazepam; oxazepam; pharmacokinetics; anxiety;
D O I
10.1002/hup.408
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The relationship between the cerebral pharmacokinetics of diazepam and its active metabolites (desmethyldiazepam, oxazepam) and the anxiolytic effect evaluated by the four-plates test and the light/dark test were investigated after a single intra-peritoneaI injection of diazepam, (1 mg/kg or 1.5 mg/kg). For up to 30 min after administration, the sedative effect interfered with the anxiolytic effect, thus the results of the anxiolytic effect were not interpretable. From 30 min to 60 min after administration, this interference disappeared, the cerebral level of benzodiazepines was stable (the brain elimination of diazepam was compensated for by the appearance of desmethyldiazepam followed by oxazepam) but the anxiolytic effect decreased dramatically in all the tests with diazepam I mg/kg or 1.5 mg/kg. The acute tolerance to benzodiazepines and the difference of affinity for subtypes of GABA(A) receptors between diazepam, desmethyldiazepam, oxazepam could explain this result. Copyright (C) 2002 John Wiley Sons, Ltd.
引用
收藏
页码:239 / 245
页数:7
相关论文
共 13 条
[1]
EVALUATION OF RAPID TECHNIQUE FOR DETECTING MINOR TRANQUILIZERS [J].
ARON, C ;
SIMON, P ;
LAROUSSE, C ;
BOISSIER, JR .
NEUROPHARMACOLOGY, 1971, 10 (04) :459-&
[2]
Pharmacokinetic and pharmacodynamic analysis of sedative and amnesic effects of lorazepam in healthy volunteers [J].
Blin, O ;
Simon, N ;
Jouve, E ;
Habib, M ;
Gayraud, D ;
Durand, A ;
Bruguerolle, B ;
Pisano, P .
CLINICAL NEUROPHARMACOLOGY, 2001, 24 (02) :71-81
[3]
BOISSIER JR, 1965, ARCH INT PHARMACOD T, V158, P212
[4]
BOURIN M, 1992, J PSYCHIATR NEUROSCI, V17, P72
[5]
COMPARATIVE PHARMACOKINETICS AND PHARMACODYNAMICS OF LORAZEPAM, ALPRAZOLAM AND DIAZEPAM [J].
ELLINWOOD, EH ;
HEATHERLY, DG ;
NIKAIDO, AM ;
BJORNSSON, TD ;
KILTS, C .
PSYCHOPHARMACOLOGY, 1985, 86 (04) :392-399
[6]
BENZODIAZEPINE CONCENTRATIONS IN BRAIN DIRECTLY REFLECT RECEPTOR OCCUPANCY - STUDIES OF DIAZEPAM, LORAZEPAM, AND OXAZEPAM [J].
GREENBLATT, DJ ;
SETHY, VH .
PSYCHOPHARMACOLOGY, 1990, 102 (03) :373-378
[7]
SIMULTANEOUS MODELING OF THE PHARMACOKINETIC AND PHARMACODYNAMIC PROPERTIES OF BENZODIAZEPINES .1. LORAZEPAM [J].
GUPTA, SK ;
ELLINWOOD, EH ;
NIKAIDO, AM ;
HEATHERLY, DG .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1990, 18 (02) :89-102
[8]
A new approach to the light/dark test procedure in mice [J].
Hascoët, M ;
Bourin, M .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1998, 60 (03) :645-653
[9]
SIMULTANEOUS DETERMINATION OF DIAZEPAM AND ITS ACTIVE METABOLITES IN RAT SERUM, BRAIN AND CEREBROSPINAL-FLUID BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
KLOCKOWSKI, PM ;
LEVY, G .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1987, 422 :334-339
[10]
SENSITIVE DETERMINATION OF DIAZEPAM AND N-DESMETHYLDIAZEPAM IN HUMAN MATERIAL USING CAPILLARY GAS CHROMATOGRAPHY-MASS SPECTROMETRY [J].
KUDO, K ;
NAGATA, T ;
KIMURA, K ;
IMAMURA, T ;
NODA, M .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1988, 431 (02) :353-359